Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors

NCT01803282 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

236

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer
Non-small Cell Lung Cancer
Esophagogastric Cancer
Colorectal Cancer
Breast Cancer

Interventions

DRUG: Andecaliximab
DRUG: Gemcitabine
DRUG: Nab-paclitaxel
DRUG: Carboplatin
DRUG: Pemetrexed
DRUG: Leucovorin
DRUG: Oxaliplatin
DRUG: 5-FU
DRUG: Bevacizumab
DRUG: Irinotecan
DRUG: Paclitaxel

Sponsor

Gilead Sciences